Cargando…
T.08.5 THE OVERALL SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) PANDEMIC IMPACT ON METABOLIC (DYSFUNCTION) ASSOCIATED FATTY LIVER DISEASE. A PRELIMINARY EVALUATION
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065947/ http://dx.doi.org/10.1016/S1590-8658(22)00448-0 |
_version_ | 1784699700817952768 |
---|---|
author | Romeo, M. Dallio, M. Cipullo, M. Olivieri, S. Iadanza, G. Sangineto, M. Ventriglia, L. Scognamiglio, F. Federico, A. |
author_facet | Romeo, M. Dallio, M. Cipullo, M. Olivieri, S. Iadanza, G. Sangineto, M. Ventriglia, L. Scognamiglio, F. Federico, A. |
author_sort | Romeo, M. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9065947 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-90659472022-05-04 T.08.5 THE OVERALL SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) PANDEMIC IMPACT ON METABOLIC (DYSFUNCTION) ASSOCIATED FATTY LIVER DISEASE. A PRELIMINARY EVALUATION Romeo, M. Dallio, M. Cipullo, M. Olivieri, S. Iadanza, G. Sangineto, M. Ventriglia, L. Scognamiglio, F. Federico, A. Dig Liver Dis Poster Presentations Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. 2022-05 2022-05-04 /pmc/articles/PMC9065947/ http://dx.doi.org/10.1016/S1590-8658(22)00448-0 Text en © 2022 Editrice Gastroenterologica Italiana S.r.l. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Poster Presentations Romeo, M. Dallio, M. Cipullo, M. Olivieri, S. Iadanza, G. Sangineto, M. Ventriglia, L. Scognamiglio, F. Federico, A. T.08.5 THE OVERALL SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) PANDEMIC IMPACT ON METABOLIC (DYSFUNCTION) ASSOCIATED FATTY LIVER DISEASE. A PRELIMINARY EVALUATION |
title | T.08.5 THE OVERALL SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) PANDEMIC IMPACT ON METABOLIC (DYSFUNCTION) ASSOCIATED FATTY LIVER DISEASE. A PRELIMINARY EVALUATION |
title_full | T.08.5 THE OVERALL SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) PANDEMIC IMPACT ON METABOLIC (DYSFUNCTION) ASSOCIATED FATTY LIVER DISEASE. A PRELIMINARY EVALUATION |
title_fullStr | T.08.5 THE OVERALL SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) PANDEMIC IMPACT ON METABOLIC (DYSFUNCTION) ASSOCIATED FATTY LIVER DISEASE. A PRELIMINARY EVALUATION |
title_full_unstemmed | T.08.5 THE OVERALL SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) PANDEMIC IMPACT ON METABOLIC (DYSFUNCTION) ASSOCIATED FATTY LIVER DISEASE. A PRELIMINARY EVALUATION |
title_short | T.08.5 THE OVERALL SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) PANDEMIC IMPACT ON METABOLIC (DYSFUNCTION) ASSOCIATED FATTY LIVER DISEASE. A PRELIMINARY EVALUATION |
title_sort | t.08.5 the overall severe acute respiratory syndrome coronavirus 2 (sars-cov-2) pandemic impact on metabolic (dysfunction) associated fatty liver disease. a preliminary evaluation |
topic | Poster Presentations |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065947/ http://dx.doi.org/10.1016/S1590-8658(22)00448-0 |
work_keys_str_mv | AT romeom t085theoverallsevereacuterespiratorysyndromecoronavirus2sarscov2pandemicimpactonmetabolicdysfunctionassociatedfattyliverdiseaseapreliminaryevaluation AT dalliom t085theoverallsevereacuterespiratorysyndromecoronavirus2sarscov2pandemicimpactonmetabolicdysfunctionassociatedfattyliverdiseaseapreliminaryevaluation AT cipullom t085theoverallsevereacuterespiratorysyndromecoronavirus2sarscov2pandemicimpactonmetabolicdysfunctionassociatedfattyliverdiseaseapreliminaryevaluation AT olivieris t085theoverallsevereacuterespiratorysyndromecoronavirus2sarscov2pandemicimpactonmetabolicdysfunctionassociatedfattyliverdiseaseapreliminaryevaluation AT iadanzag t085theoverallsevereacuterespiratorysyndromecoronavirus2sarscov2pandemicimpactonmetabolicdysfunctionassociatedfattyliverdiseaseapreliminaryevaluation AT sanginetom t085theoverallsevereacuterespiratorysyndromecoronavirus2sarscov2pandemicimpactonmetabolicdysfunctionassociatedfattyliverdiseaseapreliminaryevaluation AT ventriglial t085theoverallsevereacuterespiratorysyndromecoronavirus2sarscov2pandemicimpactonmetabolicdysfunctionassociatedfattyliverdiseaseapreliminaryevaluation AT scognamigliof t085theoverallsevereacuterespiratorysyndromecoronavirus2sarscov2pandemicimpactonmetabolicdysfunctionassociatedfattyliverdiseaseapreliminaryevaluation AT federicoa t085theoverallsevereacuterespiratorysyndromecoronavirus2sarscov2pandemicimpactonmetabolicdysfunctionassociatedfattyliverdiseaseapreliminaryevaluation |